구조모아 (StructureMoa)항암 chemical structure spider web
방문프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Recombinant (Hepatitis B Vaccine, Hepatitis B Vaccine (Recombinant)) MCM Vaccines B.V.·HIV Infections 385 trials |
|---|---|
Overview Program | Hepatitis B Vaccine (Recombinant) |
Overview Company | MCM Vaccines B.V. |
Overview Modality | ANTIBODY |
Overview Target | HIV Infections |
Overview Indication | HIV Infections; Hepatitis B |
Overview Phase | PRECLINICAL |
Overview Status | ACTIVE |
Overview Content status | Standard Database |
Overview Data Confidence | Data Confidence · Medium |
Overview Development Signal | Development Signal · Watch |
Overview Approval status | Investigational |
MoA Mechanism | target is the histidine biosynthesis pathway |
MoA Biomarker | HER2)-positive |
PK/PD Species | Mouse |
PK/PD Animal (cat.) | Mouse |
PK/PD Experiment | Pharmacokinetic |
Toxicology Species | Mouse |
Toxicology Animal (cat.) | Mouse |
Toxicology Major finding | thrombocytopenia: from "platelet counting" to ecological repair of the bone marrow |
Clinical Safety signal | thrombocytopenia: from "platelet counting" to ecological repair of the bone marrow |
Clinical Selected reported efficacy | 94.99% |
Clinical Result source | ClinicalTrials.gov NCT01341639 |
Clinical Program phase | PRECLINICAL |
Clinical Trial activity | No active/completed counts |
Clinical Trial ref | NCT01341639 |
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Recombinant (Hepatitis B Vaccine, Hepatitis B Vaccine (Recombinant)) MCM Vaccines B.V.·HIV Infections 385 trials |
|---|---|
Overview Program | Hepatitis B Vaccine (Recombinant) |
Overview Company | MCM Vaccines B.V. |
Overview Modality | ANTIBODY |
Overview Target | HIV Infections |
Overview Indication | HIV Infections; Hepatitis B |
Overview Phase | PRECLINICAL |
Overview Status | ACTIVE |
Overview Content status | Standard Database |
Overview Data Confidence | Data Confidence · Medium |
Overview Development Signal | Development Signal · Watch |
Overview Approval status | Investigational |
MoA Mechanism | target is the histidine biosynthesis pathway |
MoA Biomarker | HER2)-positive |
PK/PD Species | Mouse |
PK/PD Animal (cat.) | Mouse |
PK/PD Experiment | Pharmacokinetic |
Toxicology Species | Mouse |
Toxicology Animal (cat.) | Mouse |
Toxicology Major finding | thrombocytopenia: from "platelet counting" to ecological repair of the bone marrow |
Clinical Safety signal | thrombocytopenia: from "platelet counting" to ecological repair of the bone marrow |
Clinical Selected reported efficacy | 94.99% |
Clinical Result source | ClinicalTrials.gov NCT01341639 |
Clinical Program phase | PRECLINICAL |
Clinical Trial activity | No active/completed counts |
Clinical Trial ref | NCT01341639 |
추천 비교
추천 비교